Justices Urged To Undo Denial Of Fast Track For Gastro Drug

By Jared Foretek · May 22, 2025, 7:22 PM EDT

Vanda Pharmaceuticals Inc. is asking the U.S. Supreme Court to reverse the Food and Drug Administration's decision denying fast-track approval for its gastroparesis drug tradipitant, saying it meets the statutory standard...

To view the full article, register now.

Documents

Case Information

Case Title

Vanda Pharmaceuticals, Inc., Petitioner v. Food and Drug Administration, et al.

Case Number

24-1187

Court

Supreme Court

Nature of Suit

2899 Other Statutes APA/Review Agency

Date Filed

May 21, 2025